Finding its rhythm: Startup seeks $4M in funding for trailblazing atrial fibrillation treatment
A new Ottawa biotech startup is seeking to raise $4 million to produce groundbreaking treatments aimed at curing one of the most common heart rhythm
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
How Emotional Intelligence Can Give Business Leaders a Competitive Edge
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall